Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
NANature's Sunshine Products, Inc. logo

Nature's Sunshine Products, Inc. (NATR)

NASDAQ Capital Market · Currency in USD
$12.15 ▼ -0.26 (-2.10%)
At close: Oct 23, 4:00 PM ET. Market closed.
$12.15 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$12.41
Open
$12.38
Day's Range
$12.07 – $12.38
52 Week Range
$12.00 – $28.14
Volume
125,973
Avg. Volume
148,514
Market Cap
$213.79M
Beta (5Y Monthly)
0.81
PE Ratio (TTM)
11.91
EPS (TTM)
$1.02
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
Mar 26, 2021
1y Target Est
$31.00

Profile: Nature's Sunshine Products, Inc.

Sector
Consumer Defensive
Industry
Packaged Foods
Full-time employees
806
CEO
Kenneth G. Romanzi

Nature's Sunshine Products, Inc. is a natural health and wellness enterprise that primarily manufactures and distributes a wide array of nutritional supplements and personal care products. The company's operational reach spans several continents, including Asia, Europe, North America, and Latin America. Its comprehensive nutritional offerings cater to general well-being, providing support for blood sugar regulation, bone density, cellular vitality, cognitive sharpness, joint mobility, mood balance, sexual wellness, sleep quality, athletic performance, and visual acuity.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate $0.27 · Revenue est. $129.50M
DateEst.Actual
Aug 6, 2026$0.27$0.21Miss
May 7, 2026$0.21$0.30Beat
Mar 10, 2026$0.19$0.30Beat
Nov 6, 2025$0.19$0.36Beat
Jul 31, 2025$0.18$0.35Beat
May 6, 2025$0.17$0.25Beat

Analyst view

Consensus price target
$31.00 ▲ +155.1%
Range $25.00 – $37.00
Rating: Buy
Buy 50% · Hold 50% · Sell 0%

Get free alerts on NATR and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.